Global Opioid Induced Side Effects Treatment Market
According to Intent Market Research, the Opioid Induced Side Effects Treatment Market is expected to grow from USD 5.4 Billion in 2024-e at a CAGR of 17.4% to touch USD 14.1 Billion by 2030. The Opioid Induced Side Effects Treatment Market is dominated by key players such as Valeant Pharmaceuticals (Bausch Health), Progenics Pharmaceuticals, Endo Pharmaceuticals, Pfizer Inc., NPS Pharmaceuticals (Shire), and Mallinckrodt Pharmaceuticals.